USPTO serial 74545050
LOTUS LOTUS BIOCHEMICAL CORPORATION
Reviewed by CopyMark Law Group
Reg. 2031398Status 710
- Filing date
- Status date
- Registration date
- Jan 21, 1997
- Examiner
- JENKINS JR, CHARLES L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LOTUS LOTUS BIOCHEMICAL CORPORATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
A. Willard Lester
A WILLARD LESTERP O BOX 178140 E SPRING STWYTHEVILLE, VA 24382Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for - (1) the treatment of psychoneurotic patients with depression and/or anxiety; depression and/or anxiety associated with alcoholism; depression and/or anxiety associated with organic disease; psychotic depressive disorders associated with anxiety including involutional depression and manic-depressive disorders; (2) therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called "histaminic cephalalgia"; (3) the management of exogenous obesity as a short-term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction; (4) the treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible; (5) the treatment of moderate to severe vasomotor symptoms associated with the menopause; atrophic vaginitis; kraurosis vulvae; female hypogonadism; female castration; primary ovarian failure; breast cancer (for palliation only) in appropriately selected women and men with metastatic disease; prostatic carcinoma-palliative therapy of advanced disease | SECTION 8 - CANCELLED | Jan 2, 1993 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Lotus Biochemical Corporation
- Other trademarks owned by Lotus Biochemical Corporation
- Other trademarks owned by Lotus Biochemical Corporation
- Other trademarks in Class 005
- Similar marks named LOTUS LOTUS BIOCHEMICAL CORPORATION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 26, 2004 | PAPER RECEIVED | — | |
| Oct 25, 2003 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 21, 1997 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 7, 1996 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 5, 1996 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 27, 1996 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 1995 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 1995 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 13, 1995 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 1994 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 1994 | DOCK | ASSIGNED TO EXAMINER | — |